Gout Rounds: 5 New Developments

Slideshow

Primary care can do more to help reduce gout morbidity, says a new review-plus 4 more studies on gout treatment and prevention.

A recent review of the state of gout treatment in the US calls for primary care to play a larger and more significant role. Four more new studies address comorbidities and gout treatment and preventions.Scroll through the slides above for the latest findings.Find links to studies/abstracts below.Sources1. Both High and Low Uric Acid Boost Cardiovascular Risk2. MI Risk is High in Gout and Other Arthritis3. Uric Acid Level Runs Low With DASH Diet4. Ketogenic Diet Douses Gout Flares5. Putting Primary Care on the Gout Care Map 

Recent Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
Investigational Drug Reduces Lp(a) in High-Risk Adults: Daily Dose / image credit: ©New Africa/AdobeStock

Investigational Drug Reduces Lp(a) in High-Risk Adults: Daily Dose

Sydney Jennings
December 4th 2024
Article

Your daily dose of the clinical news you may have missed.

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Sydney Jennings
August 30th 2023
Podcast

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

Among Stroke Survivors, GLP-1RAs, SGLT2is May Reduce Risk of Future MI, Recurrent Stroke / image credit American Heart Association

Among Stroke Survivors, GLP-1RAs, SGLT2is May Reduce Risk of Future MI, Recurrent Stroke

Grace Halsey
November 11th 2024
Article

AHA 2024. Study authors reported a 74% lower risk of death and an 84% lower risk of MI among participants taking either a GLP-1RA or an SGLT2i.

Primary Viewpoints Episode 4: Lp(a): The Next CVD Target?

Primary Viewpoints Episode 4: Lp(a): The Next CVD Target?

Patient Care Editorial Staff
October 29th 2020
Podcast

Patrick Moriarty, MD, from the University of Kansas Medical Center, discusses the role of Lp(a) as a risk factor for cardiovascular disease and the phase 3 trials of a potential treatment.

Beer and Cider Associated with Higher Risk of Gout in Both Sexes vs Other Alcohol Types / Image credit: ©David Prahl/AdobeStock

Beer and Cider Associated with Higher Risk of Gout in Both Sexes vs Other Alcohol Types

Sydney Jennings
October 14th 2024
Article

Higher alcohol intake was associated with a greater risk of gout for both sexes, but the correlation was stronger in men than women, according to a recent study.

COVID-19 Linked to Long-Term Risk of MACE, Especially Among Adults with non-O Blood Types

COVID-19 Linked to Long-Term Risk of MACE, Especially Among Adults with non-O Blood Types

Sydney Jennings
October 9th 2024
Article

Prior SARS-CoV-2 infection was associated with a 2-fold increased risk for MACE for up to 3 years, even among people with no history of CVD, in a new analysis of UK Biobank data.

© 2024 MJH Life Sciences

All rights reserved.